ATE12779T1 - Verfahren zur herstellung eines antithrombinheparin-komplexes sowie diesen komplex enthaltende pharmazeutische mischungen. - Google Patents

Verfahren zur herstellung eines antithrombinheparin-komplexes sowie diesen komplex enthaltende pharmazeutische mischungen.

Info

Publication number
ATE12779T1
ATE12779T1 AT81107365T AT81107365T ATE12779T1 AT E12779 T1 ATE12779 T1 AT E12779T1 AT 81107365 T AT81107365 T AT 81107365T AT 81107365 T AT81107365 T AT 81107365T AT E12779 T1 ATE12779 T1 AT E12779T1
Authority
AT
Austria
Prior art keywords
complex
antithroman
processes
preparation
mixtures containing
Prior art date
Application number
AT81107365T
Other languages
German (de)
English (en)
Inventor
Robert E Jordan
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of ATE12779T1 publication Critical patent/ATE12779T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT81107365T 1980-09-30 1981-09-17 Verfahren zur herstellung eines antithrombinheparin-komplexes sowie diesen komplex enthaltende pharmazeutische mischungen. ATE12779T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19217080A 1980-09-30 1980-09-30
EP81107365A EP0048898B1 (en) 1980-09-30 1981-09-17 Method for the production of an antithrombin-heparin complex and pharmaceutical compositions containing the complex

Publications (1)

Publication Number Publication Date
ATE12779T1 true ATE12779T1 (de) 1985-05-15

Family

ID=22708546

Family Applications (1)

Application Number Title Priority Date Filing Date
AT81107365T ATE12779T1 (de) 1980-09-30 1981-09-17 Verfahren zur herstellung eines antithrombinheparin-komplexes sowie diesen komplex enthaltende pharmazeutische mischungen.

Country Status (7)

Country Link
EP (1) EP0048898B1 (cg-RX-API-DMAC7.html)
JP (1) JPS5788125A (cg-RX-API-DMAC7.html)
AT (1) ATE12779T1 (cg-RX-API-DMAC7.html)
AU (1) AU553260B2 (cg-RX-API-DMAC7.html)
CA (1) CA1187074A (cg-RX-API-DMAC7.html)
DE (1) DE3170001D1 (cg-RX-API-DMAC7.html)
ES (1) ES8302460A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0098814B1 (en) * 1982-06-10 1986-10-15 KabiVitrum AB Antithrombin-heparin complex
US4689323A (en) * 1983-09-26 1987-08-25 Miles Laboratories, Inc. Covalently bound heparin--antithrombin-III complex
EP0209924A1 (en) * 1985-07-12 1987-01-28 Akzo N.V. New anti-trombosis agent based on glycosaminoglycan, process for its preparation, and pharmaceutical compositions
DK148890D0 (da) * 1990-06-19 1990-06-19 Novo Nordisk As Farmaceutisk praeparat
SK280864B6 (en) * 1991-01-11 2000-08-14 Laboratoires Glaxo Sa Acridine derivatives, process for their preparation, and pharmaceutical compositions based thereon
AT405905B (de) * 1997-03-25 1999-12-27 Immuno Ag Neue verwendung von antithrombin iii
EP1362127B1 (en) * 2001-01-26 2007-11-07 The General Hospital Corporation Serpin drugs for treatment of hiv infection and method of use thereof
FR2889078B1 (fr) * 2005-07-27 2007-11-02 Aventis Pharma Sa Nouvelle methode de chromatographie d'affinite d'antithrombine iii

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6040859B2 (ja) * 1977-07-27 1985-09-12 喜温 三浦 抗血栓性人工医療材料
JPS597693B2 (ja) * 1978-01-07 1984-02-20 株式会社ミドリ十字 抗トロンビン製剤及びその製法

Also Published As

Publication number Publication date
ES505911A0 (es) 1982-12-01
JPH0153650B2 (cg-RX-API-DMAC7.html) 1989-11-15
DE3170001D1 (en) 1985-05-23
EP0048898A2 (en) 1982-04-07
EP0048898A3 (en) 1982-09-15
AU553260B2 (en) 1986-07-10
EP0048898B1 (en) 1985-04-17
ES8302460A1 (es) 1982-12-01
JPS5788125A (en) 1982-06-01
CA1187074A (en) 1985-05-14
AU7578581A (en) 1982-04-08

Similar Documents

Publication Publication Date Title
DE122005000002I1 (de) Verwendung von Venlafaxin oder eines Aryloxy-Propanaminderivates zur Herstellung eines Medikaments zur Behandlung von Inkontinenz.
DE69023073D1 (de) Herstellung von Vorrichtungen mittels lithographischer Prozesse.
DE68923727D1 (de) Verfahren zur Herstellung eines aktiven Matrixsubstrats.
ATE14525T1 (de) Trockene, sterile, gamma-globulin angebundene saeule und verfahren zur herstellung derselben.
ES2070981T3 (es) Concentrados de componente activo y nuevas combinaciones de componente activo de hojas de ginkgo biloba, sus metodos de preparacion y productos farmaceuticos que contienen los concentrados de componente activo o las combinaciones de componente activo.
DE3689943D1 (de) Degradierte Spezies eines Gewebeplasminogenaktivators, pharmazeutische Zubereitung und Verfahren zur Herstellung derselben.
PT89534A (pt) Processo para a preparacao de composicoes farmaceuticas anticoagulantes contendo como ingrediente activo proteina c ou proteina c activada combinada com heparina
DE68918016D1 (de) Verfahren zur Herstellung eines Dimethyltetralins.
DE3650404D1 (de) Verfahren zur Herstellung eines Mittels zur Blutstillung.
ATE9354T1 (de) Die blutkoagulation aktivierende produkte und verfahren zu deren herstellung.
ATE12779T1 (de) Verfahren zur herstellung eines antithrombinheparin-komplexes sowie diesen komplex enthaltende pharmazeutische mischungen.
ATE4707T1 (de) Pyridyl- und imidazopyridyloxypropanolamine, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen sie enthaltend.
DE69009614D1 (de) Verfahren zur Herstellung von (S)-gamma-Hydroxymethyl-alpha,beta-Butenolid.
DE3675197D1 (de) Pyridinylpyrimidin-derivate, verfahren zu deren herstellung und diese als wirksamen stoff enthaltende pflanzenkrankheiten-schutzmittel.
ATA260590A (de) Glyzerinderivate, verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen
ES2062145T3 (es) 1,8-naftiridinas substituidas.
ATE10094T1 (de) 3,4-bis-substituierte 1,2,5-oxadiazol-2-oxide, verfahren zu ihrer herstellung, und sie enthaltende pharmazeutische zubereitungen.
DE3851306D1 (de) Verfahren zur Herstellung von optisch-aktiven 1,2-Diolen.
KR900007816A (ko) 사이클로프로필-치환된 아졸릴메틸카비놀, 이의 제조방법 및 약제로서의 이의 용도
ATE4216T1 (de) 3-hydrocarbylthio-2-acyloxypropyl 2trimethylammonioethyl phosphate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen.
LU80859A1 (de) Phenylharnstoff-derivate,verfahren zur herstellung dieser verbindungen sowie diese enthaltendes selektives herbizides mittel
DE3770551D1 (de) Verfahren zur herstellung eines pulvers mit grosser wundheilungsfaehigkeit aus der rinde des baumes namens "mimosa tenuiflora poir".
ATE70444T1 (de) Topische methotrexatzubereitung zur behandlung hyperproliferativer epithelerkrankungen.
ATE4806T1 (de) Isoxazolderivat, dessen herstellung und pharmazeutische zusammensetzungen die es enthalten.
SE8304821L (sv) Arabinogalaktaner, deras framstellning och kompositioner innehallande desamma